Related Experiment Videos
[Carbohydrate-deficient glycoprotein syndrome]
1Odense Universitetshospital, børneafdeling H.
Ugeskrift for Laeger
|November 21, 1994
Summary
Carbohydrate-deficient glycoprotein syndrome is a rare genetic disorder affecting multiple body systems, particularly the nervous system. Elevated levels of carbohydrate-deficient transferrin in the blood confirm this diagnosis.
Area of Science:
- Biochemistry
- Genetics
- Neurology
Background:
- Carbohydrate-deficient glycoprotein syndrome (CDGS) is a rare, inherited disorder.
- It presents with multisystemic involvement, notably severe neurological impairment.
- Biochemical hallmark includes deficient glycosylation of serum glycoproteins.
Observation:
- A patient presented with psychomotor retardation and dysmorphic features.
- Clinical manifestations included seizures, hepatopathy, and pericardial effusions.
- Cerebral CT scans revealed cortical and central atrophy.
Findings:
- Serum transferrin, a key glycoprotein, exhibits the most significant carbohydrate defect in CDGS.
- Elevated levels of carbohydrate-deficient serum transferrin serve as a reliable diagnostic marker.
- The presented patient's diagnosis was confirmed by markedly high levels of this marker.
Implications:
- Early identification of CDGS is crucial due to its severe neurological impact.
- Serum transferrin analysis offers a practical diagnostic tool for this rare condition.
- Understanding the biochemical basis aids in potential therapeutic strategies for CDGS.